Trikafta 100-50-75 MG/75MG PKT 14S
Ended Awarded
- Contract number
- SPE2DB25FZP97
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,805
Award facts
- Contract value 100% obligated
- $37,804.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, valued at $37,804.69, was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The award carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499.9 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure contracts without specific set-aside designations. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems across the nation. Trikafta, a cystic fibrosis treatment, represents one of the specialized pharmaceutical products within the vendor's extensive portfolio of medications supporting military and federal healthcare operations. The one-day delivery timeline reflects the urgent nature of pharmaceutical supply requirements for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FZP97?
SPE2DB25FZP97 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FZP97 worth?
The government has obligated $37,805 on SPE2DB25FZP97.
Is contract SPE2DB25FZP97 an order under another contract?
Yes. SPE2DB25FZP97 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZP97 competed?
The extent of competition for SPE2DB25FZP97 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award